Related Experiment Videos
Identification of a candidate tumor-suppressor gene specifically activated during Ras-induced senescence
Marta Barradas1, Efstathios S Gonos, Zoë Zebedee
1Department of Immunology and Oncology, Spanish National Center of Biotechnology (CSIC), Campus de Cantoblanco, Madrid E-28049, Spain.
Abstract:
Normal cells display protective responses against oncogenes. Notably, oncogenic Ras triggers an irreversible proliferation arrest that is reminiscent of replicative senescence and that is considered a relevant tumor-suppressor mechanism. Here, we have used microarrayed filters to identify genes specifically upregulated in Ras-senescent human fibroblasts. Among the initial set of genes selected from the microarrays, we found the cell-cycle inhibitor p21(Cip1/Waf1), thus validating the potency of the screening to identify markers and mediators of Ras-senescence. A group of six genes, formed by those more highly upregulated during Ras-senescence, was analyzed in further detail to evaluate their specificity. In particular, we examined their expression in cells overexpressing Ras but rendered resistant to Ras-senescence by the viral oncoprotein E1a; also, we have studied their expression during replicative senescence, organismal aging, H(2)O(2)-induced senescence, and DNA damage. In this manner, we have identified a novel gene, RIS1 (for Ras-induced senescence 1), which is not upregulated in association to any of the above-mentioned processes, but exclusively during Ras-senescence. Furthermore, RIS1 is also upregulated by the transcriptional factor Ets2, which is a known mediator of Ras-induced senescence. Interestingly, RIS1 is located at chromosomal position 3p21.3 and, more specifically, it is included in a short segment of just 1 Mb previously defined by other investigators for its tumor-suppressor activity. In summary, we report the identification of a novel gene, RIS1, as a highly specific marker of Ras-induced senescence and a candidate tumor-suppressor gene.
Insights
Researchers identified a novel gene, RIS1 (Ras-induced senescence 1), that specifically marks Ras-induced senescence. This gene, a potential tumor suppressor, is exclusively upregulated during this process, offering a new marker for cancer research.
Area of Science:
- Molecular Biology
- Oncology
- Cellular Senescence
Background:
- Oncogenic Ras triggers cellular responses, including proliferation arrest resembling senescence, a key tumor-suppressor mechanism.
- Identifying specific markers for Ras-induced senescence is crucial for understanding its role in tumor suppression.
Purpose of the Study:
- To identify genes specifically upregulated during Ras-induced senescence in human fibroblasts.
- To characterize novel genes as potential markers and mediators of Ras-induced senescence and tumor suppression.
Main Methods:
- Utilized microarrayed filters to screen for genes upregulated in Ras-senescent human fibroblasts.
- Validated screening by identifying the cell-cycle inhibitor p21(Cip1/Waf1).
- Analyzed the specificity of highly upregulated genes across various senescence models and cellular conditions.
Main Results:
- Identified a novel gene, RIS1 (Ras-induced senescence 1), exclusively upregulated during Ras-senescence.
- RIS1 expression is specifically induced by the transcriptional factor Ets2, a known mediator of Ras-induced senescence.
- RIS1 is located on chromosome 3p21.3, a region previously identified for its tumor-suppressor activity.
Conclusions:
- RIS1 is a highly specific marker for Ras-induced senescence.
- RIS1 is a candidate tumor-suppressor gene, potentially playing a role in cancer prevention.
- The findings provide new insights into the molecular mechanisms of oncogene-induced senescence and tumor suppression.